FDA Inspection 1297348 — Azurity Pharmaceuticals, Inc.
The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on December 12, 2025 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Woburn, MA (United States)